Pioneer of Neglected Drugs and Point of Care Diagnostics
Diseases in focus
With advanced research, we create innovative drugs & diagnostics for a
healthier tomorrow.
Jolly Healthcare creates innovative drugs , rapid diagnostics and bio-therapeutics trusted by physicians around the world. We have re-developed 20 patented products to help people in over 65 countries live to their fullest potential. Our manufacturing facilities are approved by USFDA, SAHPRA, KFDA and WHO.
Cryptococcal meningitis is a serious infection of the brain and spinal column that can occur in people living with HIV.
Wilson Disease
Wilson disease is a rare genetic disorder characterized by excess copper stored in various body tissues, particularly the liver, brain, and corneas of the eyes.
Congenital Hyperinsulinism
Congenital hyperinsulinism (HI) is the most frequent cause of severe, persistent hypoglycemia caused by excessive insulin secretion in newborn babies and children.
Complex Partial Seizures(Epilepsy)
A Refractory complex partial seizure (CPS) is a type of seizure that starts in a specific area of the brain and can affect consciousness.
Rare Diseases
affect
0%
of World Population
There are approx
0k
rare disease
FDA lists
0
drugs in the
short supply
Reasons of shortage of Drugs
Active ingredients shortage
Price capping by Govt
Regulatory issues
Manufacturing problems
Supply chain management
Advantage of Rapid Testing
Low cost
Portability
Simplicity
Remote Accessibility
Superior Sensitivity & Specificity
Our Ever Growing Coverage
Scientific Officers
0+
Hospitals Served
0+
Distribution Points
0+
Countries Export
0+
"Doctors" is at the core of
our thinking
our planning
our actions
The future of healthcare
At Jolly healthcare we believe in Doctor-first approach research and manufacturing to offer high- quality and affordable medicine.
SCIENCE & INNOVATION
From the Concept to the Drug
JOLLY covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
Partnering is of key importance for Jolly healthcare. It allows further developing Jolly Healthcare’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.
In the field of rare diseases the Jolly healthcare team develops and investigates therapy options for patients with rare Neglected diseases – commitment and appreciation are the essence of our cooperative work.